Type 2 Diabetic Patients with Ischemic Stroke: Decreased Insulin Sensitivity and Decreases in Antioxidant Enzyme Activity Are Related to Different Stroke Subtypes

Table 1

Clinical characteristics and laboratory analyses in type 2 diabetic patients and nondiabetics with different subtypes of ishemic stroke: atherotrombotic infarction (ATI) and lacunar infarction (LI).

	Groups
	A	B	C	D	E	F	𝑃 value
	T2D+	T2D+	T2D+	T2D−	T2D−	Healthy
	ATI+	LI+	Stroke−	ATI+	LI+	Controls
𝑛 (M/F)	30 (16/14)	30 (16/14)	33 (15/18)	30 (15/15)	30 (15/15)	33 (15/18)	NS
Age (years)	56.9±1.67	56.03±2.51	56.42±3.05	57.07±2.88	56.00±2.03	56.97±2.42	NS
Duration of diabetes (years)	4.73±1.53	5.34±1.00	4.65±2.01	—	—	—	NS
Duration from onset of ischaemic stroke (years)	1.23±0.43	1.30±0.24	—	1.03±0.21	1.09±0.21	—	NS
HbA1c (%)	7.39±0.20	7.30±0.14	7.31±0.43	5.52±0.31	5.37±0.31	4.89±0.26	NS
Total cholesterol (mmol/L)	6.98±0.91	6.81±0.68	7.03±0.62	6.25±0.71	6.15±0.63	6.14±0.74	NS
Triglyceride (mmol/L)	2.20±0.37	2.26±0.38	2.18±0.26	1.90±0.22	2.00±0.29	1.87±0.35	NS
LDL-c (mmol/L)	5.21 ± 0.42*	4.81±0.14	4.47±0.29	4.34 ± 0.43*	4.05±0.55	3.71±0.49	𝑃<0.05
HDL-c (mmol/L)	0.94±0.17	1.01±0.40	1.01±0.15	0.99±0.27	1.05±0.16	1.11±0.21	NS
Hypertension (𝑛, %)	22 (73.3%)**	21 (70.0%)**	23 (69.7%)**	22 (73.3%)**	22 (66.7%)**	0 (0%)	𝑃<0.001
Smoking (𝑛, %)	10 (33.3%)	11 (36.7%)	12 (36.4%)	10 (33.3%)	11 (36.7%)	12 (36.4%)	NS

Data are 𝑛, means ± SEM.
^∗𝑃<0.05 A versus B, C and D versus E, F.
^∗∗𝑃<0.001 A, B, C, D, E versus F.